Singapore
The firm has closed more than five mandates with Asian LPs in the past year.
1
Vietnam's Tevo lands $10m from Singapore's PvX to fuel user growth
2
Brookfield eyes $1.8b first close for maiden RMB energy transition fund in China
3
SEA Digest: OJK mulls IDX ownership limit; Gojek Singapore rolls out capped fares
4
Circolife secures $4.5m funding, and other India deals worth $255m
5
SE Asia drives China's clean energy export boom: Maguire
More Stories
Two speeds define SE Asia’s private capital funds market
Asian capital widens private market footprint: Ardian
Japan’s Nissha withdraws investment in Vietnam-based USM Healthcare
German retailer Aldi acquires stake in PH hard discounter DALI
Singapore-Sri Lankan VC targets $10m for second fund
The firm focuses on India, Australia, and SE Asia.
Rest of Asia
Asian target could bring bigger presence or more clients, William Huffman says.
The firm is in discussions to hire a Partner in Singapore.
Greater China
This gives it an edge over traditional Western pharmaceutical giants.
The firm also sees opportunities in the mid-market space in Japan.
Infrastructure as an asset class has typically been generating stable, long-term returns.
The firm’s private wealth AUM hit $17.8 billion by March 31, 2026.
It is also on track to close its second PE Fund.
The fintech sees stablecoins becoming an increasingly visible part of global money movement.
